<?xml version = '1.0' encoding = 'UTF-8'?>
<?xml-stylesheet href="/rss/styledrssBMC.css" type="text/css"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:extra="http://www.biomedcentral.com/xml/schemas/extra/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:cc="http://web.resource.org/cc/">
	<channel rdf:about="http://www.biomedcentral.com/rss">
		<extra:info rdf:parseType="Literal">
			<html:div xmlns:html="http://www.w3.org/1999/xhtml" style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif">
				<html:span style="font-weight:bold">This is an RSS newsfeed from BioMed Central</html:span>
				<html:br/>
				<html:span style="font-size: 12px;">It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit <html:br/><html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">http://www.biomedcentral.com/info/about/rss/</html:a><html:br/>
				</html:span>
			</html:div>
		</extra:info>
		<title>BMC Cardiovascular Disorders - Most viewed articles</title>
		<link>http://www.biomedcentral.com/bmccardiovascdisord/mostviewed/</link>
		<description>Most viewed articles in last 30 days from BMC Cardiovascular Disorders (ISSN 1471-2261) published by 
				
				BioMed Central
		</description>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
         <items>
            <rdf:Seq>
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2261/8/13"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2261/8/20"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2261/8/18"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2261/2/15"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2261/8/17"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2261/8/12"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2261/8/15"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2261/8/7"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2261/7/11"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2261/8/10"/>			    
            
            </rdf:Seq>
        </items>
    </channel>
    
		<item rdf:about="http://www.biomedcentral.com/1471-2261/8/13">
            
            <title>Effect of garlic on blood pressure: A systematic review and meta-analysis</title>
			<description>Background:
Non-pharmacological treatment options for hypertension have the potential to reduce the risk of cardiovascular disease at a population level. Animal studies have suggested that garlic reduces blood pressure, but primary studies in humans and non-systematic reviews have reported mixed results. With interest in complementary medicine for hypertension increasing, it is timely to update a systematic review and meta-analysis from 1994 of studies investigating the effect of garlic preparations on blood pressure.
Methods:
We searched the Medline and Embase databases for studies published between 1955 and October 2007. Randomised controlled trials with true placebo groups, using garlic-only preparations, and reporting mean systolic and/or diastolic blood pressure (SBP/DBP) and standard deviations were included in the meta-analysis. We also conducted subgroup meta-analysis by baseline blood pressure (hypertensive/normotensive), for the first time. Meta-regression analysis was performed to test the associations between blood pressure outcomes and duration of treatment, dosage, and blood pressure at start of treatment.
Results:
Eleven of 25 studies included in the systematic review were suitable for meta-analysis. Meta-analysis of all studies showed a mean decrease of 4.6 &#177; 2.8 mm Hg for SBP in the garlic group compared to placebo (n = 10; p = 0.001), while the mean decrease in the hypertensive subgroup was 8.4 &#177; 2.8 mm Hg for SBP (n = 4; p &lt; 0.001), and 7.3 &#177; 1.5 mm Hg for DBP (n = 3; p &lt; 0.001). Regression analysis revealed a significant association between blood pressure at the start of the intervention and the level of blood pressure reduction (SBP: R = 0.057; p = 0.03; DBP: R = -0.315; p = 0.02).
Conclusion:
Our meta-analysis suggests that garlic preparations are superior to placebo in reducing blood pressure in individuals with hypertension.</description>
			<link>http://www.biomedcentral.com/1471-2261/8/13</link>		
			<dc:creator>Karin Ried, Oliver R Frank, Nigel P Stocks, Peter Fakler and Thomas Sullivan</dc:creator>
			<dc:source>BMC Cardiovascular Disorders 2008, 8:13</dc:source>
			<dc:subject>Number of accesses: 983</dc:subject>
			<dc:date>2008-06-16</dc:date>
			<dc:identifier>doi:10.1186/1471-2261-8-13</dc:identifier>
			
			
							
					<prism:publicationName>BMC Cardiovascular Disorders</prism:publicationName>
					
			
							
					<prism:issn>1471-2261</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>13</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-06-16</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2261/8/20">
            
            <title>Prevalence of prehypertension and its relationship to risk factors for cardiovascular disease in Jamaica: analysis from a cross-sectional survey</title>
			<description>Background:
Recent studies have documented an increased risk of cardiovascular disease (CVD) in persons with systolic blood pressures of 120-139mmHg and/or diastolic blood pressures of 80-89mmHg, classified as prehypertension in the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.  In this paper we estimate the prevalence of prehypertension in Jamaica and evaluate the relationship between prehypertension and other risk factors for CVD. 
Methods:
The study used data from participants in the Jamaica Lifestyle Survey conducted from 2000-2001. A sample of 2012 persons, 15-74 years old, completed an interviewer administered questionnaire and had anthropometric and blood pressure  measurements performed by trained observers using standardized procedures.  Fasting glucose and total cholesterol were measured using a capillary blood sample.  Analysis yielded crude, and sex-specific prevalence estimates for prehypertension and other CVD risk factors. Odds ratios for associations of prehypertension with CVD risk factors were obtained using logistic regression. 
Results:
The prevalence of prehypertension among Jamaicans was 30% (95% confidence interval [CI] 27%- 33%). Prehypertension was more common in males, 35% (CI 31%-39%), than females, 25% (CI 22%-28%). Almost 46% of participants were overweight; 19.7% were obese; 14.6% had hypercholesterolemia; 7.2% had diabetes mellitus and 17.8% smoked cigarettes.  With the exception of cigarette smoking and low physical activity, all the CVD risk factors had significantly higher prevalence in the prehypertensive and hypertensive groups (p for trend &lt;0.001) compared to the normotensive group. Odds of obesity, overweight, high cholesterol and increased waist circumference were significantly higher among younger prehypertensive participants (15-44 years-old) when compared to normotensive young participants, but not among those 45-74 years-old. Among men, being prehypertensive increased the odds of having >/=3 CVD risk factors versus no risk factors almost three-fold (odds ratio [OR] 2.8[CI 1.1-7.2]) while among women the odds of >/=3 CVD risk factors was increased two-fold (OR 2.0[CI 1.3-3.8])
Conclusions:
Prehypertension occurs in 30% of Jamaicans and is associated with increased prevalence of other CVD risk factors. Health-care providers should recognize the increased CVD risk of prehypertension and should seek to identify and treat modifiable risk factors in these persons.  </description>
			<link>http://www.biomedcentral.com/1471-2261/8/20</link>		
			<dc:creator>Trevor S Ferguson, Novie O M Younger, Marshall K Tulloch-Reid, Marilyn B Lawrence Wright, Elizabeth M Ward, Deanna E Ashley and Rainford J Wilks</dc:creator>
			<dc:source>BMC Cardiovascular Disorders 2008, 8:20</dc:source>
			<dc:subject>Number of accesses: 462</dc:subject>
			<dc:date>2008-08-28</dc:date>
			<dc:identifier>doi:10.1186/1471-2261-8-20</dc:identifier>
			
			
							
					<prism:publicationName>BMC Cardiovascular Disorders</prism:publicationName>
					
			
							
					<prism:issn>1471-2261</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>20</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-08-28</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2261/8/18">
            
            <title>Healthy Hearts &#8211; A community-based primary prevention programme to reduce coronary heart disease</title>
			<description>Background:
The ten year probability of cardiovascular events can be calculated, but many people are unaware of their risk and unclear how to reduce it. The aim of this study was to assess whether a community based intervention, for men and women aged between 45 and 64 years without pre-existing coronary heart disease, would reduce their Framingham scores when reassessed one year later.
Methods:
Individuals in the relevant age group from a defined geographical area were sent an invitation to attend for an assessment of their cardiovascular risk. Individuals with pre-existing cardiovascular disease or terminal illness were excluded. The invitation was in the form of a "Many Happy Returns" card with a number of self-screening questions including the question, "If you put the enclosed string around your waist, is it too short?" The card contained a red 80 cm piece of string in the case of women, or a green 90 cm piece of string in the case of men. At the assessment appointment, Framingham scores were calculated and a printout was given to each individual. Advice was provided for relevant risk factors identified using agreed guidelines. If appropriate, onward referral was also made to a GP, dietician, an exercise referral scheme, or to smoking cessation services, using a set of guidelines. Individuals were sent a second invitation one year later to return for re-assessment.Results and discussion2031 individuals were asked to self-assess their eligibility to participate, 596 individuals attended for assessment and 313 of these attended for follow-up one year later. The mean reduction in the Framingham risk score, was significantly lower at one year (0.876, 95% CI 0.211 to 1.541, p = 0.01). The mean 10-year risk of CHD at baseline was 13.14% (SD 9.18) and had fallen at follow-up to 12.34% (SD 8.71), a mean reduction of 6.7% of the initial 10-year Framingham risk. If sustained, the estimated NNT to prevent each year of CHD would be 1141 (95% CI 4739 to 649) individual appointments.
Conclusion:
This community intervention for primary prevention of CHD reduces Framingham risk scores at one year in those who engage with the programme.</description>
			<link>http://www.biomedcentral.com/1471-2261/8/18</link>		
			<dc:creator>Gill Richardson, Hugo C van Woerden, Lucy Morgan, Rhiannon Edwards, Monica Harries, Elaine Hancock, Susan Sroczynsk and Mererid Bowley</dc:creator>
			<dc:source>BMC Cardiovascular Disorders 2008, 8:18</dc:source>
			<dc:subject>Number of accesses: 376</dc:subject>
			<dc:date>2008-07-26</dc:date>
			<dc:identifier>doi:10.1186/1471-2261-8-18</dc:identifier>
			
			
							
					<prism:publicationName>BMC Cardiovascular Disorders</prism:publicationName>
					
			
							
					<prism:issn>1471-2261</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>18</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-07-26</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2261/2/15">
            
            <title>Myocardial bridging as a cause of acute myocardial infarction: a case report</title>
			<description>Background:
Systolic compression of a coronary artery by overlying myocardial tissue is termed myocardial bridging. Myocardial bridging usually has a benign prognosis, but some cases resulting in myocardial ischemia, infarction and sudden cardiac death have been reported. We are reporting a case of myocardial bridging which was complicated with acute myocardial infarction associated with inappropriate blood donation.Case presentationA 33 year-old-man was admitted to our emergency with acute anteroseptal myocardial infarction after a blood donation. The electrocardiography showed sinus rhythm and was consistent with an acute anteroseptal myocardial infarction. We decided to perform primary percutanous intervention (PCI). Myocardial bridging was observed in the mid segment of the left anterior descending coronary artery on coronary angiogram. PCI was canceled and medical follow up was decided. Blood transfusion was made because he had a deep anemia. A normal hemaglobin level and clinical reperfusion was achieved after ten hours by blood transfusion. At the one year follow up visit, our patient was healthy and had no cardiac complaints.
Conclusions:
Myocardial bridging may cause acute myocardial infarction in various clinical conditions. Although the condition in this case caused profound anemia related acute myocardial infarction, its treatment and management was unusual.</description>
			<link>http://www.biomedcentral.com/1471-2261/2/15</link>		
			<dc:creator>Ramazan Akdemir, Huseyin Gunduz, Yunus Emiroglu and Cihangir Uyan</dc:creator>
			<dc:source>BMC Cardiovascular Disorders 2002, 2:15</dc:source>
			<dc:subject>Number of accesses: 310</dc:subject>
			<dc:date>2002-09-21</dc:date>
			<dc:identifier>doi:10.1186/1471-2261-2-15</dc:identifier>
			
			
							
					<prism:publicationName>BMC Cardiovascular Disorders</prism:publicationName>
					
			
							
					<prism:issn>1471-2261</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>15</prism:startingPage>
					
			
							
					<prism:publicationDate>2002-09-21</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2261/8/17">
            
            <title>Gender differences in trends of acute myocardial infarction events: The Northern Sweden MONICA study 1985 &#8211; 2004</title>
			<description>Background:
The registration of non-fatal and fatal MI events initiated 1985 in the WHO MONICA project has been ongoing in northern Sweden since the end of the WHO project in 1995. The purpose of the present study was to analyze gender differences in first and recurrent events, case fatality and mortality in myocardial infarction (MI) in Northern Sweden during the 20-year period 1985 &#8211; 2004.
Methods:
Diagnosed MI events in subjects aged 25&#8211;64 years in the Counties of Norrbotten and V&#228;sterbotten were validated according to the MONICA protocol. The total number of events registered up to January 1, 2005 was 11,763: 9,387 in men and 2,376 in women.
Results:
The proportion of male/female events has decreased from 5.5:1 to 3:1. For males the reductions were 30% and 70% for first and recurrent MI, respectively, and for women 0% and 40% in the 55&#8211;64 year group. For both sexes a 50% reduction in 28-day case fatality was seen in the 25&#8211;64 year-group. Mortality was reduced by 69% and 45% in men and women, respectively.
Conclusion:
First and recurrent events of myocardial infarction was markedly reduced in men over the 20-year observation period, but for women the reduction was seen only for recurrent infarctions. Case fatality, on the other hand, was markedly reduced for both sexes. As a result of the positive effects on incidence and case fatality a substantial reduction was seen in total mortality, most pronounced for men.</description>
			<link>http://www.biomedcentral.com/1471-2261/8/17</link>		
			<dc:creator>Dan Lundblad, Lars Holmgren, Jan-H&#229;kan Jansson, Ulf N&#228;slund and Mats Eliasson</dc:creator>
			<dc:source>BMC Cardiovascular Disorders 2008, 8:17</dc:source>
			<dc:subject>Number of accesses: 307</dc:subject>
			<dc:date>2008-07-25</dc:date>
			<dc:identifier>doi:10.1186/1471-2261-8-17</dc:identifier>
			
			
							
					<prism:publicationName>BMC Cardiovascular Disorders</prism:publicationName>
					
			
							
					<prism:issn>1471-2261</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>17</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-07-25</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2261/8/12">
            
            <title>The Metabolic Syndrome and the immediate antihypertensive effects of aerobic exercise: a randomized control design</title>
			<description>Background:
The metabolic syndrome (Msyn) affects about 40% of those with hypertension. The Msyn and hypertension have a common pathophysiology. Exercise is recommended for their treatment, prevention and control. The influence of the Msyn on the antihypertensive effects of aerobic exercise is not known. We examined the influence of the Msyn on the blood pressure (BP) response following low (LIGHT, 40% peak oxygen consumption, VO2peak) and moderate (MODERATE, 60% VO2peak) intensity, aerobic exercise.
Methods:
Subjects were 46 men (44.3 &#177; 1.3 yr) with pre- to Stage 1 hypertension (145.5 &#177; 1.6/86.3 &#177; 1.2 mmHg) and borderline dyslipidemia. Men with Msyn (n = 18) had higher fasting insulin, triglycerides and homeostasis model assessment (HOMA) and lower high density lipoprotein than men without Msyn (n = 28) (p &lt; 0.01). Subjects consumed a standard meal and 2 hr later completed one of three randomized experiments separated by 48 hr. The experiments were a non-exercise control session of seated rest and two cycle bouts (LIGHT and MODERATE). BP, insulin and glucose were measured before, during and after the 40 min experiments. Subjects left the laboratory wearing an ambulatory BP monitor for the remainder of the day. Repeated measure ANCOVA tested if BP, insulin and glucose differed over time among experiments in men without and with the Msyn with HOMA as a covariate. Multivariable regression analyses examined associations among BP, insulin, glucose and the Msyn.
Results:
Systolic BP (SBP) was reduced 8 mmHg (p &lt; 0.05) and diastolic BP (DBP) 5 mmHg (p = 0.052) after LIGHT compared to non-exercise control over 9 hr among men without versus with Msyn. BP was not different after MODERATE versus non-exercise control between Msyn groups (p &#8805; 0.05). The factors accounting for 17% of the SBP response after LIGHT were baseline SBP (&#946; = -0.351, r2 = 0.123, p = 0.020), Msyn (&#946; = 0.277, r2 = 0.077, p = 0.069), and HOMA (&#946; = -0.124, r2 = 0.015, p = 0.424). Msyn (r2 = 0.096, p = 0.036) was the only significant correlate of the DBP response after LIGHT.
Conclusion:
Men without the Msyn respond more favorably to the antihypertensive effects of lower intensity, aerobic exercise than men with the Msyn. If future work confirms our findings, important new knowledge will be gained for the personalization of exercise prescriptions among those with hypertension and the Msyn.</description>
			<link>http://www.biomedcentral.com/1471-2261/8/12</link>		
			<dc:creator>Linda S Pescatello, Bruce E Blanchard, Jaci L Van Heest, Carl M Maresh, Heather Gordish-Dressman and Paul D Thompson</dc:creator>
			<dc:source>BMC Cardiovascular Disorders 2008, 8:12</dc:source>
			<dc:subject>Number of accesses: 295</dc:subject>
			<dc:date>2008-06-10</dc:date>
			<dc:identifier>doi:10.1186/1471-2261-8-12</dc:identifier>
			
			
							
					<prism:publicationName>BMC Cardiovascular Disorders</prism:publicationName>
					
			
							
					<prism:issn>1471-2261</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>12</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-06-10</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2261/8/15">
            
            <title>RAS gene polymorphisms, classical risk factors and the advent of coronary artery disease in the Portuguese population</title>
			<description>Background:
Several polymorphisms within the renin-angiotensin system cluster of genes have been associated with the advent of coronary artery disease (CAD) or related pathologies. We investigated the distribution of 5 of these polymorphisms in order to find any association with CAD development and distinguish if any of the biochemical and behavioural factors interact with genetic polymorphisms in the advent of the disease.
Methods:
ACE I/D (rs4340), ACE A11860G (rs4343), AT1R A1166C (rs5186), AGT T174M (rs4762) and AGT M235T (rs699) gene polymorphisms were PCR-RFLP analysed in 298 CAD patients and 510 controls from Portugal. Several biochemical and behavioural markers were obtained.
Results:
ACE I/D DD and ACE11860 GG genotypes are risk factors for CAD in this population. The simultaneous presence of ACE I/D I and ACE11860 A alleles corresponds to a significant trend towards a decrease in CAD incidence. We found several synergistic effects between the studied polymorphisms and classical risk factors such as hypertension, obesity, diabetes and dyslipidaemia: the presence of the DD genotype of ACE I/D (and also ACE11860 GG) increases the odds of developing CAD when associated to each one of these classical risk factors, particularly when considering the male and early onset CAD subgroup analysis; AGT235 TT also increases the CAD risk in the presence of hypertension and dyslipidaemia, and AT1R1166 interacts positively with hypertension, smoking and obesity.
Conclusion:
ACE polymorphisms were shown to play a major role in individual susceptibility to develop CAD. There is also a clear interaction between RAS predisposing genes and some biochemical/environmental risk factors in CAD onset, demonstrating a significant enhancement of classical markers particularly by ACE I/D and ACE11860.</description>
			<link>http://www.biomedcentral.com/1471-2261/8/15</link>		
			<dc:creator>Ana I Freitas, Isabel Mendon&#231;a, Maria Bri&#243;n, Miguel M Sequeira, Roberto P Reis, Angel Carracedo and Ant&#243;nio Brehm</dc:creator>
			<dc:source>BMC Cardiovascular Disorders 2008, 8:15</dc:source>
			<dc:subject>Number of accesses: 252</dc:subject>
			<dc:date>2008-07-17</dc:date>
			<dc:identifier>doi:10.1186/1471-2261-8-15</dc:identifier>
			
			
							
					<prism:publicationName>BMC Cardiovascular Disorders</prism:publicationName>
					
			
							
					<prism:issn>1471-2261</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>15</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-07-17</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2261/8/7">
            
            <title>Rapid short-duration hypothermia with cold saline and endovascular cooling before reperfusion reduces microvascular obstruction and myocardial infarct size</title>
			<description>Background:
The aim of this study was to evaluate the combination of a rapid intravenous infusion of cold saline and endovascular hypothermia in a closed chest pig infarct model.
Methods:
Pigs were randomized to pre-reperfusion hypothermia (n = 7), post-reperfusion hypothermia (n = 7) or normothermia (n = 5). A percutaneous coronary intervention balloon was inflated in the left anterior descending artery for 40 min. Hypothermia was started after 25 min of ischemia or immediately after reperfusion by infusion of 1000 ml of 4&#176;C saline and endovascular hypothermia. Area at risk was evaluated by in vivo SPECT. Infarct size was evaluated by ex vivo MRI.
Results:
Pre-reperfusion hypothermia reduced infarct size/area at risk by 43% (46 &#177; 8%) compared to post-reperfusion hypothermia (80 &#177; 6%, p &lt; 0.05) and by 39% compared to normothermia (75 &#177; 5%, p &lt; 0.05). Pre-reperfusion hypothermia infarctions were patchier in appearance with scattered islands of viable myocardium. Pre-reperfusion hypothermia abolished (0%, p &lt; 0.001), and post-reperfusion hypothermia significantly reduced microvascular obstruction (10.3 &#177; 5%; p &lt; 0.05), compared to normothermia: (30.2 &#177; 5%).
Conclusion:
Rapid hypothermia with cold saline and endovascular cooling before reperfusion reduces myocardial infarct size and microvascular obstruction. A novel finding is that hypothermia at the onset of reperfusion reduces microvascular obstruction without reducing myocardial infarct size. Intravenous administration of cold saline combined with endovascular hypothermia provides a method for a rapid induction of hypothermia suggesting a potential clinical application.</description>
			<link>http://www.biomedcentral.com/1471-2261/8/7</link>		
			<dc:creator>Matthias G&#246;tberg, Goran K Olivecrona, Henrik Engblom, Martin Ugander, Jesper van der Pals, Einar Heiberg, H&#229;kan Arheden and David Erlinge</dc:creator>
			<dc:source>BMC Cardiovascular Disorders 2008, 8:7</dc:source>
			<dc:subject>Number of accesses: 236</dc:subject>
			<dc:date>2008-04-10</dc:date>
			<dc:identifier>doi:10.1186/1471-2261-8-7</dc:identifier>
			
			
							
					<prism:publicationName>BMC Cardiovascular Disorders</prism:publicationName>
					
			
							
					<prism:issn>1471-2261</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>7</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-10</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2261/7/11">
            
            <title>Flow mediated dilation of the brachial artery: an investigation of methods requiring further standardization</title>
			<description>Background:
In order to establish a consistent method for brachial artery reactivity assessment, we analyzed commonly used approaches to the test and their effects on the magnitude and time-course of flow mediated dilation (FMD), and on test variability and repeatability. As a popular and noninvasive assessment of endothelial function, several different approaches have been employed to measure brachial artery reactivity with B-mode ultrasound. Despite some efforts, there remains a lack of defined normal values and large variability in measurement technique.
Methods:
Twenty-six healthy volunteers underwent repeated brachial artery diameter measurements by B-mode ultrasound. Following baseline diameter recordings we assessed endothelium-dependent flow mediated dilation by inflating a blood pressure cuff either on the upper arm (proximal) or on the forearm (distal).
Results:
Thirty-seven measures were performed using proximal occlusion and 25 with distal occlusion. Following proximal occlusion relative to distal occlusion, FMD was larger (16.2 &#177; 1.2% vs. 7.3 &#177; 0.9%, p &lt; 0.0001) and elongated (107.2 s vs. 67.8 s, p = 0.0001). Measurement of the test repeatability showed that differences between the repeated measures were greater on average when the measurements were done using the proximal method as compared to the distal method (2.4%; 95% CI 0.5&#8211;4.3; p = 0.013).
Conclusion:
These findings suggest that forearm compression holds statistical advantages over upper arm compression. Added to documented physiological and practical reasons, we propose that future studies should use forearm compression in the assessment of endothelial function.</description>
			<link>http://www.biomedcentral.com/1471-2261/7/11</link>		
			<dc:creator>Alon Peretz, Daniel F Leotta, Jeffrey H Sullivan, Carol A Trenga, Fiona N Sands, Mary R Aulet, Marla Paun, Edward A Gill and Joel D Kaufman</dc:creator>
			<dc:source>BMC Cardiovascular Disorders 2007, 7:11</dc:source>
			<dc:subject>Number of accesses: 228</dc:subject>
			<dc:date>2007-03-21</dc:date>
			<dc:identifier>doi:10.1186/1471-2261-7-11</dc:identifier>
			
			
							
					<prism:publicationName>BMC Cardiovascular Disorders</prism:publicationName>
					
			
							
					<prism:issn>1471-2261</prism:issn>
					
			
							
					<prism:volume>7</prism:volume>
					
			
							
					<prism:startingPage>11</prism:startingPage>
					
			
							
					<prism:publicationDate>2007-03-21</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2261/8/10">
            
            <title>A randomised trial of a 5 week, manual based, self-management programme for hypertension delivered in a cardiac patient club in Shanghai</title>
			<description>Background:
In Shanghai there are 1.2 million people with hypertension, many of whom have difficulty in affording medical treatment. Community based, anti-hypertensive clubs have been created to provide health education but education alone is often ineffective. Lifestyle change programmes have shown some potential for reducing blood pressure but in previous trials have required specialist staff and extensive contact. We have previously demonstrated that self-management programmes delivered by health professionals, such as a nurse who has had short training in self-management techniques can change health behaviour and reduce symptoms. This study was designed to evaluate the benefits of a simple, cognitive-behavioural, self-management programme for hypertension based around a hypertension manual and delivered in the setting of a community anti-hypertensive club in Shanghai.MethodThe method was a pragmatic randomised controlled trial with an intention-to-treat analysis. Adult patients with mild-to-moderate primary hypertension, waiting to join a neighbourhood anti-hypertension club, were randomised to the self-management programme or to an information only control procedure. They attended the group treatment sessions on 4 occasions over 5 weeks for education combined with goal setting for lifestyle change and an introduction to exercise. The main outcome measures were: changes in blood pressure; blood total cholesterol; diet; activity level and health related quality of life 1 month and 4 months after the end of treatment.
Results:
A total of 140 adults with mild-to-moderate primary hypertension took part. All of the main outcomes showed beneficial changes. Four months after the end of treatment the mean blood pressure differences between groups were systolic 10.15 mm Hg (P &lt; 0.001, 95% CI 7.25&#8211;13.05), and diastolic 8.29 mmHg (P &lt; 0.001, 95% CI 6.71&#8211;9.88). Patients in the intervention group also had significantly reduced weight, lowered blood total cholesterol, increased physical activity and improved quality of life.
Conclusion:
Patients with mild-to-moderate primary hypertension attending a 5 week, group and manual based, cognitive-behavioural self-management programme, delivered through a voluntary club in Shanghai experienced a significant reduction in blood pressure.Trial registrationCurrent Controlled Trials ISRCTN73114566</description>
			<link>http://www.biomedcentral.com/1471-2261/8/10</link>		
			<dc:creator>Feng Xue, Wen Yao and Robert J Lewin</dc:creator>
			<dc:source>BMC Cardiovascular Disorders 2008, 8:10</dc:source>
			<dc:subject>Number of accesses: 219</dc:subject>
			<dc:date>2008-05-06</dc:date>
			<dc:identifier>doi:10.1186/1471-2261-8-10</dc:identifier>
			
			
							
					<prism:publicationName>BMC Cardiovascular Disorders</prism:publicationName>
					
			
							
					<prism:issn>1471-2261</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>10</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-05-06</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
		
	<cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
         <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks"/>
	</cc:License>
</rdf:RDF>
